ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 10 mg - donepezil - donepezil - treatment of mild to moderately severe alzheimer's dementia.

ישראל - עברית - Ministry of Health

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

ישראל - עברית - Ministry of Health

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 3 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

ישראל - עברית - Ministry of Health

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementiasymptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

ישראל - עברית - Ministry of Health

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 6 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

ישראל - עברית - Ministry of Health

dexcel ltd, israel - captopril - טבליה - captopril 12.5 mg - captopril - ace inhibitors, plain - hypertension, congestive heart failure, insulin dependent diabetic nephropathey in hypertensive and non hypertensive patients in cases where the serum creatinine level < 2.5 mg/dl.left ventricular dysfunction after myocardial infarction. captopril is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction < or equals to 40 % and to reduce the incidence of overt heart failure and subsequent hospitalization for congestive heart failure in these patients.

ישראל - עברית - Ministry of Health

unipharm ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 10 mg - anticholinesterases - treatment of mild to moderately severe alzheimer`s dementia.

ישראל - עברית - Ministry of Health

unipharm ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 5 mg - anticholinesterases - treatment of mild to moderately severe alzheimer`s dementia.

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - cabergoline - טבליה - cabergoline 0.5 mg - dopa and dopa derivatives - treatment of hyperprolactinemic disorders.cabotrim is indicated for the treatment of dysfunctions associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation and galactorrhea. cabotrim is indicated in patients with prolactin-secreting pituitary adenomas (micro-and macroprolactinomas), idiopathic hyperprolactinemia, or empty sella syndrome with associated hyperprolactinemia. inhibition and supression of lactation .

ישראל - עברית - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.